Addex Therapeutics (NASDAQ:ADXN – Get Free Report) is scheduled to release its earnings data before the market opens on Monday, November 11th. Analysts expect Addex Therapeutics to post earnings of ($0.07) per share for the quarter.
Addex Therapeutics (NASDAQ:ADXN – Get Free Report) last announced its quarterly earnings results on Monday, September 30th. The company reported ($1.77) EPS for the quarter, missing the consensus estimate of ($0.07) by ($1.70). The business had revenue of $0.13 million for the quarter, compared to analyst estimates of $0.26 million. Addex Therapeutics had a negative return on equity of 190.29% and a net margin of 463.11%. On average, analysts expect Addex Therapeutics to post $10 EPS for the current fiscal year and $-6 EPS for the next fiscal year.
Addex Therapeutics Trading Down 0.8 %
Shares of NASDAQ:ADXN opened at $10.55 on Friday. The stock has a market capitalization of $11.18 million, a PE ratio of -6.43 and a beta of 1.78. Addex Therapeutics has a 1 year low of $5.00 and a 1 year high of $27.90. The firm has a fifty day moving average price of $10.35 and a 200 day moving average price of $9.24.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Addex Therapeutics
Addex Therapeutics Company Profile
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder.
Read More
- Five stocks we like better than Addex Therapeutics
- The 3 Best Retail Stocks to Shop for in August
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Investing In Automotive Stocks
- MarketBeat Week in Review – 11/4 – 11/8
- What Are the U.K. Market Holidays? How to Invest and Trade
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Addex Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addex Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
